Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

320 ARTÍCULOS , VIENDO DEL 301 AL 315

Optimizing mild cognitive impairment for discriminating dementia risk in the general older population

Stephan BC, Savva GM, Brayne C, Bond J, McKeith IG, Matthews FE; Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Am J Geriatr Psychiatry. 2010 Aug;18(8):662-73. doi: 10.1097/jgp.0b013e3181e0450d.

Preventing Alzheimer's disease and cognitive decline

Williams JW, Plassman BL, Burke J, Benjamin S.

Evid Rep Technol Assess (Full Rep). 2010 Apr;(193):1-727.

[Language disorders in ALS/FTLD]

Ichikawa H.

Rinsho Shinkeigaku. 2010 Nov;50(11):1014-6. doi: 10.5692/clinicalneurol.50.1014.

Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease

Fiala M, Veerhuis R.

Exp Gerontol. 2010 Jan;45(1):57-63. doi: 10.1016/j.exger.2009.08.003. Epub 2009 Aug 21.

Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications

Ho L, Fivecoat H, Wang J, Pasinetti GM.

Exp Gerontol. 2010 Jan;45(1):15-22. doi: 10.1016/j.exger.2009.09.007. Epub 2009 Sep 29.

Origins, controversies and recent developments of the MCI construct

Gainotti G.

Curr Alzheimer Res. 2010 May;7(3):271-9. doi: 10.2174/156720510791050858.

Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls

von Känel R, Ancoli-Israel S, Dimsdale JE, Mills PJ, Mausbach BT, Ziegler MG, Patterson TL, Grant I.

Gerontology. 2010;56(1):41-50. doi: 10.1159/000264654. Epub 2009 Dec 3.

Genetic risk factors and candidate biomarkers for Alzheimer's disease

Scapagnini G, Caruso C, Vasto S, Pascale A, Romeo L, D'Agata V, Intrieri M, Sapere N, Li Volti G.

Front Biosci (Schol Ed). 2010 Jan 1;2(2):616-22. doi: 10.2741/s89.

Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease

Iuliano L, Monticolo R, Straface G, Spoletini I, Gianni W, Caltagirone C, Bossù P, Spalletta G.

J Alzheimers Dis. 2010;21(4):1383-92. doi: 10.3233/jad-2010-100780.

Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men

Chu LW, Tam S, Wong RL, Yik PY, Song Y, Cheung BM, Morley JE, Lam KS.

J Alzheimers Dis. 2010;21(4):1335-45. doi: 10.3233/jad-2010-100027.

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O.

J Alzheimers Dis. 2010;21(4):1119-28. doi: 10.3233/jad-2010-100207.

Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis

Xin XY, Ding JQ, Chen SD.

J Alzheimers Dis. 2010;19(4):1283-94. doi: 10.3233/JAD-2010-1329.

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

Krautwald M, Münch G.

Exp Gerontol. 2010 Oct;45(10):744-51. doi: 10.1016/j.exger.2010.03.001. Epub 2010 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias